Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sixth Wave Innovations Inc SIXWF

Sixth Wave Innovations Inc. is a Canada-based nanotechnology company with patented technologies. The Company is focused on the extraction and detection of target substances at the molecular level using specialized molecularly imprinted polymers (MIPs). The Company’s product brands include AMIPs, IXOS and Affinity. The IXOS is a line of extraction polymers formulated for deployment in the gold... see more

GREY:SIXWF - Post Discussion

Sixth Wave Innovations Inc > SIXW mgmt, get on with it
View:
Comment by Onadime on May 19, 2022 1:04pm
How realtically do you think Sixw will make revenue this year ?  seems like goal post just keep moving  sad how a company can give us revenue projections multiple times through the years and not deliver once. 
Comment by throwaway11 on May 20, 2022 8:43pm
Seems to be MOUs out the yin yang. Psychedelics extraction, livestock pathogen detection etc. We have to hope each of these yields extraordinarily because it certainly costs a lot to get each fully developed given the cost of time / cash burn with this company.
Comment by Onadime on May 24, 2022 9:02am
Hopefully these MOUs come in revenues before more dilution    affinity seems to be starting in June.  Assuming proven revenues Septemberish  Amips was suppose to have prototypes done in March and applying for hc/fda approval shortly after. Still no updates on this but hopefully soon as June is fast approaching. If they can get a government approval this should give the ...more  
Comment by throwaway11 on May 24, 2022 2:02pm
Endless anonymous selling drove this down to almost nothing. Now everyone is looking at the company, sees the management paying themselves handsomely despite very little revenue, financings being done at prices 1/3 of what most shareholders paid. nobody wants to buy, even with great news releases like today. Gosh golly jee whiz, I wonder why?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities